Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose randomized trial of AMG 827 in moderate to severe psoriasis
2009-013539-39Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in psoriasis comparing AMG 827 multiple-dose with Placebo (2 arms). Primary endpoint: Percent improvement from baseline in PASI at week 12. Started Oct 2009; status: completed.
02
Drugs
brodalumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2009-013539-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013539-39.